References
- McKenna R M, Wilkins J A, Warrington R J. Lymphokine production in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 1988; 15: 1639–42
- Zvaifler N J, Firestein G S. Cytokines in chronic inflammatory synovitis. Scand J Rheumatol 1988; 17(76)203–10
- Hopkins S J. Cytokines and eicosanoids in rheumatic diseases. Ann Rheum Dis 1990; 49: 207–11
- Hart D A, Fritzler M J. Regulation of plasminogen activators and their inhibitors in rheumatic diseases: new understanding and the potential for new directions. J Rheumatol 1989; 16: 1184–91
- Medcalf R L, Hamilton J A. Human synovial fibroblasts produce urokinase-type plasminogen activator. Arthritis Rheum 1986; 29: 1397–401
- Vitti G, Hamilton J A. Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid. Arthritis Rheum 1988; 31: 1046–51
- Ziff M. Role of cytokines in rheumatoid synovitis. Scand J Rheumatol 1988; 17(76)211–5
- Browning J. Interferons and rheumatoid arthritis: insight into interferon biology?. Immunol Today 1987; 8: 372–4
- Vasalli J D, Baccino D, Belin D. A cellular binding site for the M, 55,000 form of the human plasminogen activator urokinase. J Cell Biol 1985; 100: 86–92
- Blasi F, Vassalli J D, Dano K. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol 1987; 104: 801–4
- Kirchheimer J C, Nong Y H, Remold H G. IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes. J Immunol 1988; 141: 4229–34
- Kirchheimer J C, Remold H G. Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes. J Immunol 1989; 143: 2634–9
- Kirchheimer J C, Remold H G, Wanivenhaus A, Binder B R. Increased proteolytic activity on the surface of monorytes from patients with rheumatoid arthritis. Arthritis Rheum 1991; 34: 1430–3
- Bunning R AD, Russell R GG. The effect of tumor necrosis factor alpha and gamma-interferon on the resorption of human articular cartilage and on the production of prostaglandin E and of caseinase activity by human articular chondrocytes. Arthritis Rheum 1989; 32: 780–4
- Mochan E, Uhl J, Newton R. Evidence that interleukin-1 induction of synovial cell plasminogen activator is mediated via prostaglandin E2 and cAMP. Arthritis Rheum 1986; 29: 1078–84
- Leizer T, Clarris B J, Ash P E, van Damme J, Saklatvala J, Hamilton J A. Interleukin-1 beta and interleukin-1 alpha stimulate the plasminogen activator activity and prostaglandin E, levels of human synovial cells. Arthritis Rheum 1987; 30: 562–6
- Arnet F C, Edworthy S M, Bloch D A, Mc Shane D J, Fries J F, Cooper N S, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
- Steinbrocker O, Traeger C H, Batterman R C. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659–62
- Yamagata N, Kobayashi K, Kasama T, Fukushima T, Tabata M, Yonega I, et al. Multiple Cytokine activities and loss of interleukin-2 inhibitor in synovial fluids of patients with rheumatoid arthritis. J Rheumatol 1988; 15: 1623–7
- Kirchheimer J C, Remold H G. Functional characteristica of receptor bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors. Blood 1989; 74: 1396–402
- LU H, Mirshahi M, Kiref P, Soria C, Soria J, Mishal Z, et al. Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cells. Biochem. & Biophys. Res. Commun. 1988; 155: 418–22
- Bruckner A, Filderman A E, Kirchheimer J C, Binder B R, Remold H G. Endogenous receptor bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 und Calu-1. Cancer Res 1992; 52: 3043–7
- Fenner H. Future trends in non-steroidal anti-inflammatory drug therapy. Scand J Rheumatol 1988; 17(73)28–32
- Arner E C, Pratta M A. Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture. Arthritis Rheum 1989; 32: 288–97
- Dayer J M, de Rochmonteix B, Burrus B, Demczuk S, Dinarello C A. Human recombinant interleukin-1 stimulate collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 1986; 77: 645–8
- Fibbi G, Serni U, Pucci M, Caldini R, Magnelli L, Del Rosso M. Plasminogen activators and tiaprofenic acid in inflammation. A preliminary study. Drugs 1988; 35(1)9–14
- Ridley M G, Kingsley G, Pitzalis C, Panayi G S. Monocytes activation in rheumatoid arthritis: evidence for in situ activation and differentiation in joints. Br J Rheumatol 1990; 29: 84–8
- Matucci-Cerinic M, Lombardi A, Lotti T, Pignone A, Senesi C, Buzzi R, et al. Fibrinolytic activity in the synovial membrane of osteoarthritis. Br J Rheumatol 1990; 29: 249–53
- Cooper N S, Soren A, McEwen C. Diagnostic specificity of synovial lesions. Hum Pathol 1981; 12: 314–28